FGF21 levels correlate with various cardiometabolic conditions, and higher FGF21 expression is associated with cardiovascular risk factors such as chronic inflammation, obesity, hypertriglyceridemia, and elevated liver enzymes [91,92]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.